Defiance Daily Target 2X Long OSCR ETF
OSCX
NASDAQ Global Select- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Address
- 234 West Florida Street Milwaukee United States of America 53204
- IPO Date
- Sep 24, 2025
- Website
- defianceetfs.com
- Similar Companies
- Business
- Defiance Daily Target 2x Long OSCR ETF (OSCX) is an exchange-traded fund that seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oscar Health, Inc. Class A (NYSE: OSCR), a technology-driven health insurance company. The fund employs derivatives including swap agreements with counterparties such as Marex, Nomura, Clearstreet, and Cantor, as well as listed options contracts; it holds collateral in U.S. Treasury bills, government obligations funds like First American Government Obligations Fund, and cash equivalents. OSCX is non-diversified, actively managed for short-term tactical trading by knowledgeable investors aware of leverage risks, compounding effects, and potential principal loss even if OSCR rises over periods longer than one day; it distributes weekly and operates in the trading-leveraged equity category. Launched on September 24, 2025, by Defiance ETFs LLC, headquartered at 450 West 42nd Street in New York, OSCX trades on Nasdaq and targets U.S. investors seeking amplified exposure to Oscar Health—a full-stack technology platform offering health insurance to individuals, families, and small businesses—without requiring a margin account. The fund's inception marked Defiance's expansion into single-stock leveraged products, providing the first 2x long ETF focused on OSCR amid growing interest in healthcare innovators. No major partnerships, acquisitions, funding rounds, or operational changes have been reported since launch, with recent activity centered on daily rebalancing and performance tracking as of November 2025.